• Product NameLevetiracetam
  • CasNo. 102767-28-2
  • MFC8H14N2O2
  • MW170.211
  • Purity
  • AppearanceWhite crystalline powder
  • Packing
  • Contact usInquiry

Product Details

CasNo: 102767-28-2

MF: C8H14N2O2

Appearance: White crystalline powder

Chinese Manufacturer Supply Levetiracetam 102767-28-2 Cheapest Price

  • Molecular Formula:C8H14N2O2
  • Molecular Weight:170.211
  • Appearance/Colour:White crystalline powder 
  • Vapor Pressure:1.78E-06mmHg at 25°C 
  • Melting Point:118-119 °C 
  • Refractive Index:1.518 
  • Boiling Point:395.9 °C at 760 mmHg 
  • Flash Point:193.2 °C 
  • PSA:63.40000 
  • Density:1.168 g/cm3 
  • LogP:0.51090 

102767-28-2(Cas 102767-28-2) Usage

General Description

Chemical 102767-28-2, also known as Resmethrin, is a synthetic pyrethroid insecticide and acaricide used for the control of a wide range of household and agricultural pests. It is commonly formulated as an aerosol spray or fogger for indoor pest control and is effective against mosquitoes, flies, ants, and cockroaches. Resmethrin works by disrupting the function of the nervous system in insects, leading to paralysis and death. It is generally considered to have low toxicity to humans and other mammals when used according to label instructions, but it is important to follow safety precautions and proper application techniques when using products containing this chemical.

InChI:InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1

102767-28-2 Relevant articles

Peculiar Case of Levetiracetam and Etiracetam α-Ketoglutaric Acid Cocrystals: Obtaining a Stable Conglomerate of Etiracetam

George, Fanny,Norberg, Bernadette,Robeyns, Koen,Wouters, Johan,Leyssens, Tom

, p. 5273 - 5282 (2016)

In this contribution, we demonstrate tha...

Ugi Four-Center Three-Component Reaction as a Direct Approach to Racetams

Cioc, R?zvan C.,Schaepkens van Riempst, Lola,Schuckman, Peter,Ruijter, Eelco,Orru, Romano V. A.

, p. 1664 - 1674 (2017)

We report the synthesis of racetams, a d...

A Short Enantioselective Synthesis of (S)-Levetiracetam through Direct Palladium-Catalyzed Asymmetric N -Allylation of Methyl 4-Aminobutyrate

Albat, Dominik,Neud?rfl, J?rg-Martin,Schmalz, Hans-Günther

, p. 1089 - 1092 (2021)

An exceedingly short and enantioselectiv...

Ionic Cocrystals of Etiracetam and Levetiracetam: The Importance of Chirality for Ionic Cocrystals

Song, Lixing,Shemchuk, Oleksii,Robeyns, Koen,Braga, Dario,Grepioni, Fabrizia,Leyssens, Tom

, p. 2446 - 2454 (2019)

A striking variety of anhydrous and hydr...

Solid-state chiral resolution mediated by stoichiometry: Crystallizing etiracetam with ZnCl2

Shemchuk, Oleksii,Song, Lixing,Robeyns, Koen,Braga, Dario,Grepioni, Fabrizia,Leyssens, Tom

, p. 10890 - 10892 (2018)

Chiral resolution of racemic etiracetam ...

The sustainable synthesis of levetiracetam by an enzymatic dynamic kinetic resolution and an: Ex-cell anodic oxidation

Arndt, Sebastian,Grill, Birgit,Schwab, Helmut,Steinkellner, Georg,Pogorev?nik, Ur?ka,Weis, Dominik,Nauth, Alexander M.,Gruber, Karl,Opatz, Till,Donsbach, Kai,Waldvogel, Siegfried R.,Winkler, Margit

, p. 388 - 395 (2021)

Levetiracetam is an active pharmaceutica...

Cobalt-catalyzed asymmetric hydrogenation of enamides enabled by single-electron reduction

Friedfeld, Max R.,Zhong, Hongyu,Ruck, Rebecca T.,Shevlin, Michael,Chirik, Paul J.

, p. 888 - 893 (2018)

Identifying catalyst activation modes th...

Ternary and quaternary phase diagrams: Key tools for chiral resolution through solution cocrystallization

Springuel, Geraldine,Collard, Laurent,Leyssens, Tom

, p. 7951 - 7958 (2013)

The goal of this contribution is to guid...

Total synthesis of levetiracetam

Narczyk, Aleksandra,Mrozowicz, Micha?,Stecko, Sebastian

, p. 2770 - 2775 (2019)

Total synthesis of levetiracetam, an act...

Theoretical studies on racemization of levetiracetam: Structural movements, character of hydroxide ion and guidelines for efficient control

Li, Zhen,Wu, Chengjun,Liu, Jiazu,Li, Linwei,Sun, Changshan,Sun, Tiemin

, (2019)

Levetiracetam, a novel antiepileptic dru...

Radiosynthesis of 11C-levetiracetam: A potential marker for PET imaging of SV2A expression

Cai, Hancheng,Mangner, Thomas J.,Muzik, Otto,Wang, Ming-Wei,Chugani, Diane C.,Chugani, Harry T.

, p. 1152 - 1155 (2014)

The multistep preparation of 11C-levetir...

A short enantioselective synthesis of the antiepileptic agent, levetiracetam based on proline-catalyzed asymmetric α-aminooxylation

Kotkar, Shriram P.,Sudalai, Arumugam

, p. 6813 - 6815 (2006)

An efficient enantioselective synthesis ...

Method for synthesizing medicine for treating epilepsy by using L-2-aminobutanamide hydrochloride

-

Paragraph 0057-0058; 0062-0063; 0071-0072; 0076-0077, (2021/11/03)

The invention discloses a method for syn...

REGIOSELECTIVE OXIDATION OF HETEROCYCLIC ALPHA-AMINO AMIDES

-

Page/Page column 87-88, (2021/10/30)

The present invention relates to regiose...

102767-28-2 Process route

(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid
102849-49-0

(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid

levetiracetam
102767-28-2

levetiracetam

Conditions
Conditions Yield
(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid; With thionyl chloride; In methanol; at 45 ℃;
With ammonia; In methanol; at 20 ℃; under 2250.23 Torr; Product distribution / selectivity;
78.4%
(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid; With chloroformic acid ethyl ester; triethylamine; In tetrahydrofuran; at 0 ℃; for 0.5h;
With ammonium hydroxide; In tetrahydrofuran; for 16h;
75%
(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid; With ammonium hydroxide; triethylamine; isobutyl chloroformate; In tetrahydrofuran; at 0 ℃; for 0.5h;
With ammonium hydroxide; In tetrahydrofuran; at 20 ℃; for 11h;
72%
With ammonium hydroxide; chloroformic acid ethyl ester; triethylamine; In tetrahydrofuran; water; at 0 - 20 ℃; for 12.5h;
65%
(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid; With chloroformic acid ethyl ester; triethylamine; In tetrahydrofuran; at 0 ℃; for 0.5h;
With ammonium hydroxide; In tetrahydrofuran; at 0 - 20 ℃; enantioselective reaction;
62%
(2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid; With di-tert-butyl dicarbonate; In acetonitrile; at 10 - 15 ℃;
With pyridine; ammonium bicarbonate; In acetonitrile; at 10 - 20 ℃;
 
Multi-step reaction with 2 steps
1: triethylamine / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
2: ammonium hydroxide / water; tetrahydrofuran / 18.5 h / 0 - 20 °C / Inert atmosphere
With ammonium hydroxide; triethylamine; In tetrahydrofuran; water;
 
(S)-α-ethyl-2-oxo-1-pyrrolidineacetic acid (R)-α-methylbenzylamine salt
102916-46-1

(S)-α-ethyl-2-oxo-1-pyrrolidineacetic acid (R)-α-methylbenzylamine salt

levetiracetam
102767-28-2

levetiracetam

Conditions
Conditions Yield
(S)-α-ethyl-2-oxo-1-pyrrolidineacetic acid (R)-α-methylbenzylamine salt; With sodium hydroxide; In water; for 0.5h;
With chloroformic acid ethyl ester; In dichloromethane; at -10 ℃; for 2h;
With ammonia; In dichloromethane; at -15 - -10 ℃; for 2h; Solvent; Reagent/catalyst;
85%
Multi-step reaction with 3 steps
1.1: sodium hydroxide; water / 0.5 h / 0 - 10 °C
1.2: pH 4 - 5
2.1: toluene-4-sulfonic acid / 7 h / 60 °C
3.1: ammonia / 24 h / 0 - 10 °C
With ammonia; water; toluene-4-sulfonic acid; sodium hydroxide;
 

102767-28-2 Upstream products

  • 67118-31-4
    67118-31-4

    α-ethyl-2-oxo-1-pyrrolidineacetic acid,

  • 103833-72-3
    103833-72-3

    (R)-2-pyrrolidone-N-butyric acid

  • 102849-49-0
    102849-49-0

    (2S)-2-(2-oxopyrrolidin-1-yl)butanoic acid

  • 358629-51-3
    358629-51-3

    (S)-methyl 2-(2-oxopyrrolidin-1-yl)-2-butanoate

102767-28-2 Downstream products

  • 1351861-13-6
    1351861-13-6

    C8H8O3*C8H14N2O2

  • 664304-29-4
    664304-29-4

    (2S)-2-(2-oxo-1-pyrrolidinyl)butanenitrile

  • 102767-28-2
    102767-28-2

    α-ethyl-2-oxo-1-pyrrolidineacetamide

  • 10421-85-9
    10421-85-9

    (R)-2-chloromandelic acid

Relevant Products